Figures computed from official regulatory filings — .
Ownershipinsiders 88.55% · institutions 0.29% · short 1.2% of float
In USD · as of Oct 26, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Regencell Bioscience Holdings Ltd only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Regencell Bioscience Holdings Limited focuses on the research, development, and commercialization of Traditional Chinese Medicine (TCM) in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, TCM brain theory, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Market information source · Oct 26, 2026
SEC company identity · Oct 26, 2026
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| HUI EVANA YEE WAH | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |
| LO WILLIAM WING YAN DR | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC |